Chris Hillis: Newly Updated Choosing Wisely Canada – Hematology Recommendations
Chris Hillis, Vice President Oncology Interim and JHCC Site Executive,Chief of Oncology at Hamilton Health Sciences, Associate Professor at McMaster University Hamilton Ontario Canada, shared a post on LinkedIn:
“I’m proud to spotlight the newly updated Choosing Wisely Canada – Hematology recommendations. These evidence-based guidance developed by the Canadian Hematology Society to support thoughtful, high-value hematology care. These recommendations help clinicians and patients question practices that may not improve care and could cause harm or unnecessary cost.
Highlights include: judicious use of IVIG, evidence-based transfusion practice, and a personal favourite (vendetta): to not do an FNA when lymphoma is suspected.
I encourage colleagues across disciplines to explore these recommendations and think critically about how they apply in your practice settings.
Together, we can ensure hematology care that is safer, smarter, and more sustainable.
Thanks to Mohammad R. for leading the update.”
Stay updated with Hemostasis Today.
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026